1. A real-world analysis of characteristics and lipid-lowering therapy use in patients initiating treatment with evolocumab in Sweden. (14th October 2021) Authors: Svensson, M K; James, S; Ravn-Fischer, A; Pantev, E; Sorio-Vilela, F; Villa, G; Cars, T; Gustafsson, S; Hagstrom, E Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗